Syphilis OTC Test Developer NOWDiagnostics Raises $22.5M

 
• By Ryan Nelson
  
NOWDx entered a de novo classification request to the US FDA for its Syphilis OTC test in January. • Source: Shutterstock

More from Financing

More from Business